Revisiting: Reading a denial letter as a specification for your appeal

This follows post #9 rather than contradicting it.

The thing about Reading a denial letter that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.

Reading this Reading a denial letter thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.

I came in to disagree and I am leaving without a disagreement.

Coming back to post #57, because the follow-up matters more than the original answer.

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

It cost nothing to check and would have cost something not to.

Post #64 put the caveat in the right place and I want to underline it.

Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.

The conclusion is tentative; the arithmetic underneath it is not.

Building on post #71 rather than restating it.

I would put moderate confidence on the mainstream reading of Reading a denial letter and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

Before the thread moves on from Reading a denial letter — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.

A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.

What I would want before treating Reading a denial letter as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.